Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00632645
What this trial is testing

Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride

Who this might be right for
Huntington Disease
Assistance Publique - Hôpitaux de Paris 180
Not applicableStudy completedNCT07834112
What this trial is testing

Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder

Who this might be right for
Bipolar Disorder (BD)
Dong-Wook Kim 155
Not applicableStudy completedNCT01234454
What this trial is testing

Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI

Who this might be right for
Schizophrenia
University of North Carolina, Chapel Hill 34
Large-scale testing (Phase 3)Study completedNCT02282761
What this trial is testing

A Trial to Assess the Antipsychotic Efficacy of ITI-007

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 450
Post-approval studies (Phase 4)WithdrawnNCT01193166
What this trial is testing

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Who this might be right for
Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC
Early research (Phase 1)Study completedNCT03877562
What this trial is testing

The Effect of CORT118335 on Olanzapine-Induced Weight Gain

Who this might be right for
Antipsychotic-induced Weight Gain
Corcept Therapeutics 96
Not applicableActive Not RecruitingNCT06278246
What this trial is testing

Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

Who this might be right for
SchizophreniaSchizophreniform Disorders
Centre for Addiction and Mental Health 58
Post-approval studies (Phase 4)Ended earlyNCT00169026
What this trial is testing

Alcoholism and Schizophrenia: Effects of Clozapine

Who this might be right for
SchizophreniaDual DiagnosisSchizoaffective Disorder+3 more
Dartmouth-Hitchcock Medical Center 64
Large-scale testing (Phase 3)Study completedNCT00083668
What this trial is testing

Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 619
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770282
What this trial is testing

Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome

Who this might be right for
Schizophrenia DisorderMetabolic SyndromeAntipsychotic-induced Weight Gain+2 more
All India Institute of Medical Sciences, Bhubaneswar 600
Large-scale testing (Phase 3)Study completedNCT01421342
What this trial is testing

VA Augmentation and Switching Treatments for Improving Depression Outcomes

Who this might be right for
Major Depressive Disorder
VA Office of Research and Development 1,522
Post-approval studies (Phase 4)Study completedNCT01082588
What this trial is testing

Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisordersSchizophreniform Disorders
Massachusetts General Hospital 60
Early research (Phase 1)Study completedNCT01646827
What this trial is testing

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00309413
What this trial is testing

A Clinical Trial on the Antipsychotic Properties of Cannabidiol

Who this might be right for
SchizophreniaPsychotic Disorders
University of Cologne 29
Not applicableUnknownNCT03434210
What this trial is testing

The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Yi Li MD, PhD 110
Testing effectiveness (Phase 2)Study completedNCT00074477
What this trial is testing

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250
Large-scale testing (Phase 3)Study completedNCT00799383
What this trial is testing

Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia

Who this might be right for
Risperidone-induced Hyperprolactinemia
Chadi A. Calarge 47
Large-scale testing (Phase 3)Study completedNCT00167154
What this trial is testing

Risperidone and Suicidality in Major Depressive Disorder

Who this might be right for
Depression
University of Alabama at Birmingham 30
Not applicableStudy completedNCT00696813
What this trial is testing

Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 3,064
Not applicableStudy completedNCT01804582
What this trial is testing

The Family VOICE Study

Who this might be right for
AutismAggressionBipolar Disorder+1 more
University of Maryland, Baltimore 350
Next Page